Chemical giant Bayer challenging Europe’s neonicotinoids ban

neonic

Bayer will appeal…the recent ruling of the General Court of the European Union (EU) to ban neonicotinoids.

[T]he German multinational pharmaceutical company stated that it is concerned that the verdict, announced in April, could have far-reaching consequences for the certainty and predictability of active substance approvals in the EU.

Bayer also outlined that it stands by the safety of its products – which have been approved by regulatory bodies around the globe – and reiterates the value that neonicotinoids have for farmers in managing pests effectively.

By appealing against the verdict, Bayer aims to ensure that some general interpretations of the crop protection law established by the court are re-considered.

Read full, original article: Bayer to appeal court verdict on neonicotinoids

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.